Encouraging fair pricing, fair access, and future innovation within the US health care system | RTs not endorsements
Boston, MA
Joined January 2012
- Tweets2.9K
- Following625
- Followers5.4K
- Likes314
ICER #WeeklyView: Sarah Emond on Prescription for Better Access podcast & Parkinson’s disease Final Report conta.cc/4BMFskI
ICER retweeted
Sarah Emond’s prescription for better access? Prices set in line with value, met by streamlined access with little to no cost sharing or utilization management.
Hear the whole episode here: youtube.com/watch?v=DaFbdSgC… #PrescriptionForBetterAccess
TODAY -- ICER released a Final Evidence Report on tavapadon for Parkinson's disease. Read more: icer.org/pressreleases/insti…
ICER #WeeklyView: LPAR webinar & more on health care affordability conta.cc/3WTqglD
TODAY -- join ICER at 11 AM ET for a virtual public meeting to discuss treatments for #hypertension.
Register here:events.zoom.us/ev/AiBr45RLxk…
ICYMI -- ICER hosted a #webinar on Oct 27th to discuss this year's ICER/@WestHealth Launch Price and Access report.
Watch the webinar: youtu.be/gXnbeb6ocUs
Read the report: icer.org/news-insights/press…
#LaunchPricing #PrescriptionDrugs #FairAccess #PatientAffordability
TODAY -- Join us for a #webinar to discuss the 2026 Launch Price and Access Report findings. Register here: shorturl.at/MdkFd
#patientaccess #affordability #evidencebased #prescriptiondrugs #valuebased @WestHealth
Oct 27th, join us for a #webinar to discuss the 2026 Launch Price and Access Report findings.
Register here: shorturl.at/MdkFd
#patientaccess #affordability #evidencebased #prescriptiondrugs #valuebased
@WestHealth
The HEMA Draft Report public comment period ends Nov 2. Submit your public comments now! @NICEComms @CDA_AMC
The Health Economics Methods Advisory (#HEMA) today released a Draft Report on how HTA bodies can evaluate, present, and communicate uncertainty in #healtheconomic evaluations. #hta #populationhealth
Now accepting public comments until Nov 2. Read more: shorturl.at/mOe0F
ICER #WeeklyView: 2026 Launch Price and Access report, a psilocybin review, & more on health care spending conta.cc/3WFFSZT
This week, ICER and West Health released our 2026 Launch Price and Access Report.
There will be a public webinar on October 27, 2026 to discuss to discuss the report findings and the implications for affordability and patient access.
Register Here: events.zoom.us/ev/Asv-bJSL0L…
On October 29th, join ICER for a virtual public meeting to discuss treatments for #hypertension.
Register here: events.zoom.us/ev/AiBr45RLxk…
Institute for Clinical and Economic Review to Assess Therapy for Treatment-Resistant Depression: icer.org/wp-content/uploads/…
ICER and @WestHealth released a new “Launch Price and Access Report,” finding that the median drug launch prices continue to exceed $250,000 per year, contributing to increases in overall healthcare costs. Read more: shorturl.at/qAL1J
#DrugPricing #PatientAccess #RxPricing
ICER retweeted
"You're going to get government intervention, and it's going to be crappy." -- @icer_review's Sarah Emond at the @statnews Summit on what will happen if the healthcare system doesn't adopt a voluntary, value-focused approach to prices.
Many thanks to @statnews for inviting ICER's President and CEO Sarah Emond to speak as a panelist alongside @NPLB_org Priscilla VanderVeer at this year's #STATSummit!
When moderator ed silverman asked for one short-term solution to address the drug pricing problem in the US, Sarah highlighted the importance of tying drug price to value.
ICER #WeeklyView: an ICER Webinar, Draft Report, & Covid vax for pregnant women conta.cc/4s69s6s
Today, ICER released a Draft Evidence Report assessing the comparative clinical effectiveness and value of two new treatments for Friedreich’s Ataxia, a #rare, #genetic disorder: tinyurl.com/ycy8fb67
This draft is now open to public comments until November 11th.